Abstract
Objectives
Mitral annuloplasty (MAP) for ischemic mitral regurgitation (IMR) with advanced remodeling is often associated with recurrent mitral regurgitation (MR). We performed surgeries adjusted according to the degree of remodeling; i.e., for advanced remodeling cases, we added subvalvular repair (SVR) to MAP. This study aimed to evaluate our experience with patients with IMR.
Methods and results
Thirty patients with IMR (MR grade ≥ 2) were retrospectively analyzed. We performed MAP with SVR for 13 patients (MAP + SVR group) and MAP alone for 17 patients (MAP group). The MAP + SVR group had significantly larger left ventricular dimension and tenting height than the MAP group. Four patients (two in each group) experienced recurrence of MR (MR grade ≥ 2), and the 3-year and 5-year freedom from recurrence of MR rates were 97% and 83%, respectively. Six patients (two in the MAP group and four in the MAP + SVR group) died of cardiac causes during follow-up, and the 3-year and 5-year freedom from cardiac-related death rates were 81% and 74%, respectively. There was no difference between the 2 groups regarding freedom from recurrent MR (p = 0.6) and freedom from cardiac-related death (p = 0.1). The preoperative left ventricular end-systolic dimension was a significant predictor of cardiac death in the multivariate analysis.
Conclusion
Mitral valve repair adjusted according to the degree of remodeling progression provided durable mitral competence; however, it remains unclear if such a strategy is related to a high probability of freedom from cardiac-related death.
Similar content being viewed by others
References
Bouma W, van der Horst IC, Wijdh-den Hamer IJ, Erasmus ME, Zijlstra F, Mariani MA, et al. Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. Eur J Cardiothorac Surg. 2010;37:170–85.
Nicolini F, Agostinelli A, Vezzani A, Molardi A, Benassi F, Gallingani A, et al. Surgical treatment for functional ischemic mitral regurgitation: current options and future trends. Acta Biomed. 2015;86:17–26.
Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1995;109:676–83.
Mihos CG, Santana O. Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study. J Thorac Dis. 2016;8:E94–9. https://doi.org/10.3978/j.issn.2072-1439.2016.01.27.
Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R, et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol. 2010;106:395–401.
Nair RU, Williams SG, Nwafor KU, Hall AS, Tan LB. Left ventricular volume reduction without ventriculectomy. Ann Thorac Surg. 2001;71:2046–9.
Hvass U, Tapia M, Baron F, Pouzet B, Shafy A. Papillary muscle sling: a new functional approach to mitral repair in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg. 2003;75:809–11.
Matsui Y, Suto Y, Shimura S, Fukada Y, Naito Y, Yasuda K, et al. Impact of papillary muscles approximation on the adequacy of mitral coaptation in functional mitral regurgitation due to dilated cardiomyopathy. Ann Thorac Cardiovasc Surg. 2005;11:164–71.
Nappi F, Lusini M, Spadaccio C, Nenna A, Covino E, Acar C, et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol. 2016;67:2334–46.
Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg. 2002;74:600–1.
Langer F, Kunihara T, Hell K, Schramm R, Schmidt KI, Aicher D, et al. RING + STRING: successful repair technique for ischemic mitral regurgitation with severe leaflet tethering. Circulation. 2009;120(11 Suppl):85–91.
Fattouch K, Lancellotti P, Castrovinci S, Murana G, Sampognaro R, Corrado E, et al. Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2012;143:1352–5.
Borger MA, Murphy PM, Alam A, Fazel S, Maganti M, Armstrong S, et al. Initial results of the chordalcutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2007;133:1483–92.
Dor V, Sabatier M, Montiglio F, Civaia F, DiDonato M. Endoventricular patch reconstruction of ischemic failing ventricle. A single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev. 2004;9:269–86.
Isomura T, Horii T, Suma H, Buckberg GD, RESTORE Group. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not disease. Eur J Cardiothorac Surg. 2006;29(Suppl 1):245–50.
Zhu F, Otsuji Y, Yotsumoto G, Yuasa T, Ueno T, Yu B, et al. Mechanism of persistent ischemic mitral regurgitation after annuloplasty: importance of augmented posterior mitral leaflet tethering. Circulation. 2005;112(9 Suppl):I396–401.
Kim YH, Czer LS, Soukiasian HJ, De Robertis M, Magliato KE, Blanche C, et al. Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg. 2005;79:1895–901.
Magne J, Sénéchal M, Dumesnil JG, Pibarot P. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology. 2009;112:244–59.
Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–201.
Gelsomino S, Lorusso R, Caciolli S, Capecchi I, Rostagno C, Chioccioli M, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136:507–18.
Calafiore AM, Gallina S, Di Mauro M, Gaeta F, Iacò AL, D’Alessandro S, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg. 2001;71:1146–53.
Chan V, Levac-Martinho O, Sohmer B, Elmistekawy E, Ruel M, Mesana TG. When should the mitral valve be repaired or replaced in patients with ischemic mitral regurgitation? Ann Thorac Surg. 2017;103:742–7.
Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–53.
Suma H, Tanabe H, Uejima T, Isomura T, Horii T. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy. Eur J Cardiothorac Surg. 2009;36:280–5.
Menicanti L, Castelvecchio S, Ranucci M, Frigiola A, Santambrogio C, de Vincentiis C, et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg. 2007;134:433–41.
Virk SA, Tian DH, Sriravindrarajah A, Dunn D, Wolfenden HD, Suri RM, et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2017;154:127–36.
De Bonis M, Lapenna E, Barili F, Nisi T, Calabrese M, Pappalardo F, et al. Long-term results of mitral repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: does the technique matter? Eur J Cardiothorac Surg. 2016;50:882–9.
Mihos CG, Xydas S, Yucel E, Capoulade R, Williams RF, Mawad M, et al. Mitral valve repair and subvalvular intervention for secondary mitral regurgitation: a systematic review and meta-analysis of randomized controlled and propensity matched studies. J Thorac Dis. 2017;9(Suppl 7):582–94.
Beeri R, Yosefy C, Guerrero JL, Abedat S, Handschumacher MD, Stroud RE, et al. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study. Circulation. 2007;116(11 Suppl):I288–I293.
Beaudoin J, Levine RA, Guerrero JL, Yosefy C, Sullivan S, Abedat S, et al. Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repair. Circulation. 2013;128(11 Suppl 1):248–252.
Kusunose K, Obuchowski NA, Gillinov M, Popovic ZB, Flamm SD, Griffin BP, et al. Predictors of mortality in patients with severe ischemic cardiomyopathy undergoing surgical mitral valve intervention. J Am Heart Assoc. 2017; 6:e007163. https://doi.org/10.1161/JAHA.117.007163.
Acknowledgements
We thank Editage (http://www.editage.jp) for English language editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Furukawa, K., Yano, M., Nakamura, E. et al. Mid-term results of mitral valve repair for ischemic mitral regurgitation adjusted according to the degree of remodeling progression. Gen Thorac Cardiovasc Surg 66, 707–715 (2018). https://doi.org/10.1007/s11748-018-1000-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-018-1000-4